InsiderTrades

Form 4 for DGX Quest Diagnostics

Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001520897-26-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-20 2026-02-19 DGX Doherty Catherine T. EVP, Regional Businesses S - Sale $204.83 -1,433 68.4K -2% -$293.5K
D 2026-02-20 2026-02-18 DGX Doherty Catherine T. EVP, Regional Businesses A - Grant $0.00 +2,928 71.0K +4% $0
DM 2026-02-20 2026-02-18 DGX Doherty Catherine T. EVP, Regional Businesses F - Tax $208.12 -1,161 69.8K -2% -$241.6K
D 2026-02-20 2026-02-18 DGX Doherty Catherine T. EVP, Regional Businesses A - Grant $0.00 +13.5K 13.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-19 S D 1,433 $204.83 68,402 D — — (F3) This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
2 Common Common Stock 2026-02-18 A A 2,928 $0.00 70,996 D — — (F1) Represents an award of restricted stock units.
3 Common Common Stock 2026-02-18 F D 433 $210.01 70,563 D — — (F2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
4 Common Common Stock 2026-02-18 F D 728 $206.99 69,835 D — — (F2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
5 Derivative Non-Qualifed Stock Option (right to buy) 2026-02-18 A A 13,514 $0.00 13,514 D $204.96 · — to 2036-02-18 13,514 Common Stock (F5) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.